InnoPharm Moves Into Final Preparations as Boston Prepares for a New Generation of Pharma R&D Boston to Host Three Days of Cross-Disciplinary Innovation Across Drug Discovery, AI, Precision Medicine, Biologics and Advanced Drug Delivery

 The next generation of pharmaceutical research is being shaped by a convergence of technologies that were once considered separate fields. Artificial intelligence is entering drug discovery. Organ-chip technologies are changing how diseases and therapies are modeled. Precision medicine is redefining clinical research. Advanced biologics and delivery platforms are opening new possibilities for treatment.

These developments will take center stage at InnoPharm-2026, taking place November 2–4, 2026, in Boston, Massachusetts.

Now in its second edition, the International Conference on Innovations in Pharma R&D is entering its final stage of program development, with researchers and industry professionals preparing to meet in Boston for three days focused on what comes next in pharmaceutical R&D.

InnoPharm-2026 has been structured around this convergence.

Rather than limiting the scientific program to one specialty, the conference brings together four interconnected areas:

• Drug Discovery & Development
• AI & ML in Pharma R&D
• Clinical Research & Precision Medicine
• Drug Delivery Systems & Biologics

Technologies designed to determine not only what therapeutic is developed, but how effectively it reaches its intended target.

The result is a program designed to encourage participants to look beyond their individual specialties and understand how different innovations are beginning to converge across the drug development pipeline.

Boston Is More Than the Venue:

The choice of Boston is closely aligned with the conference's scientific focus.

Home to a dense ecosystem of pharmaceutical companies, biotechnology organizations, research institutions, hospitals, universities, and life-science startups, Boston provides a natural setting for conversations about the future of drug development.

For conference participants, InnoPharm-2026 offers an opportunity to combine scientific learning with face-to-face interaction in one of the world's most active life-science communities.

The Program Is Still Growing

The InnoPharm-2026 scientific program continues to develop as additional speakers and contributions are incorporated.

Researchers and professionals interested in contributing to the program can participate through oral presentations, poster presentations, invited talks, and other scientific opportunities, subject to program availability.

The conference will also include networking opportunities designed to encourage interactions between academic researchers, industry professionals, biotechnology innovators, and pharmaceutical R&D specialists.

Registration and Participation

InnoPharm-2026 will be held November 2–4, 2026, in Boston, Massachusetts, with a hybrid participation option.

Researchers, pharmaceutical and biotechnology professionals, clinicians, academic scientists, students, and technology innovators are invited to participate in the meeting and become part of the scientific discussions shaping the next phase of pharmaceutical R&D.

Register and explore the InnoPharm-2026 program (https://pharm-science.com/register)

Contact
Gayatri Srinivas
Conference Manager
InnoPharm-2026